• 4-Phenylbutyric Acid (4-PBA): Precision Modulation of ER Str

  2026-05-03

  Explore how 4-Phenylbutyric acid (4-PBA) enables targeted ER stress alleviation in complex cellular models. This article reveals practical assay insights and advances in apoptosis and autophagy research, grounded in the latest scientific evidence.

• Optimizing MTT Cell Viability Assays: Applied Use-Cases & Pr

  2026-05-02

  Unlock the full potential of MTT as a colorimetric cell viability assay reagent by leveraging high-purity APExBIO MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) in advanced workflows. Discover actionable protocol optimizations and troubleshooting tips informed by recent research breakthroughs in neurodegeneration.

• Bile Acid Metabolism Subtypes Reveal Key CRC Prognostic Mark

  2026-05-01

  Feng et al. (2026) identified molecular subtypes of colorectal cancer (CRC) based on bile acid metabolism and highlighted three genes—CLCA1, UGT2A3, and ZG16—as markers of immune dysfunction and prognosis. This integrative approach provides mechanistic insight into CRC tumor microenvironment heterogeneity and offers validated gene expression markers for future translational research.

• Fosinopril Sodium: Advanced ACE Inhibition for Hypertension

  2026-05-01

  Fosinopril sodium stands out as a phosphinic acid-based ACE inhibitor, offering dual renal and hepatic elimination and robust zinc ion targeting for reproducible hypertension and cardiovascular research. Leverage APExBIO’s high-purity formulation for streamlined experimental workflows, precise pharmacokinetic modeling, and optimized renal hemodynamics studies.

• Applied Protocols for (-)-Epigallocatechin gallate (EGCG) Re

  2026-04-30

  Harness the multifunctional potential of (-)-Epigallocatechin gallate (EGCG) for advanced bone regeneration, apoptosis assays, and antiviral investigations. This guide translates the latest scaffold-based delivery breakthroughs and troubleshooting tips into actionable, data-driven workflows for biomedical researchers.

• PSMD14-CARM1 Axis Drives HCC Progression via FERMT1 Activati

  2026-04-30

  This study reveals that PSMD14-mediated deubiquitination stabilizes CARM1, which in turn transcriptionally activates FERMT1 through H3R17 methylation, promoting hepatocellular carcinoma (HCC) proliferation and metastasis. These findings identify the PSMD14-CARM1-FERMT1 pathway as a potential therapeutic target for HCC intervention.

• Precision in Src Kinase Pathway Research: PP 3 as Gold Stand

  2026-04-29

  This thought-leadership article explores the mechanistic and strategic imperatives of using 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) as a rigorously validated negative control in Src kinase signaling pathway research. Drawing on the latest vascular biology insights, including landmark studies in NADPH oxidase-derived ROS signaling, the article provides actionable guidance for translational researchers seeking specificity and reproducibility in kinase inhibitor assays. The discussion synthesizes evidence from peer-reviewed literature and leading content assets, while positioning APExBIO’s PP 3 as the definitive research tool for advancing cell signaling studies.

• Dual-Metric In Vitro Evaluation of Cancer Drug Responses

  2026-04-29

  Schwartz’s dissertation introduces a dual-metric framework to distinguish proliferative arrest from cell death during in vitro anti-cancer drug testing. This approach improves the granularity and functional interpretation of angiogenesis inhibition assays and supports more accurate evaluation of VEGF pathway modulators such as Axitinib.

• Streptavidin – Cy5: Precision Biotin Detection in Oncology A

  2026-04-28

  Streptavidin – Cy5 empowers researchers with ultrasensitive, high-content biotin detection across immunohistochemistry, flow cytometry, and in situ hybridization. Its robust Cy5 fluorescent dye conjugation ensures strong signal and reproducibility in translational cancer research, streamlining workflows and troubleshooting.

• Exosomal miR-21-5p Mitigates Cisplatin-Induced Ovarian Cell

  2026-04-28

  This study demonstrates that exosomes from placental mesenchymal stem cells (PMSC-Exos) deliver miR-21-5p to ovarian granulosa cells, suppressing apoptosis by modulating the PTEN/AKT/mTOR signaling axis. The findings provide a mechanistic advance for cell-free therapeutic strategies against premature ovarian insufficiency (POI), especially in the context of chemotherapy-induced ovarian injury.

• Applied Workflows with the DiscoveryProbe Protease Inhibitor

  2026-04-27

  The DiscoveryProbe™ Protease Inhibitor Library streamlines high-throughput and high-content screening for protease inhibition, delivering robust, reproducible results in apoptosis, cancer, and infectious disease research. This guide translates core experimental workflows, comparative advantages, and troubleshooting strategies into actionable protocols for modern drug discovery labs.

• Atomic-Resolution Mechanisms of ASC-Mediated Inflammasome As

  2026-04-27

  This study provides the first atomic-resolution structures of full-length ASC filaments, clarifying how multitrack assemblies drive inflammasome formation and caspase activation. The findings have significant implications for dissecting innate immune signaling and inform the rational design of apoptosis and inflammation research tools.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-04-26

  The reference study uncovers CLCC1, a host chloride channel, as an essential mediator of membrane fusion during herpesvirus nuclear egress, resolving a major unknown in viral cell biology. This work advances understanding of nuclear envelope dynamics and host-pathogen interactions, with implications for both basic research and the development of antiviral strategies.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-04-25

  Schwartz's doctoral dissertation establishes a critical distinction between relative and fractional viability as measures of drug response in cancer models. By demonstrating that these two metrics capture different facets—growth inhibition versus cell death—the work provides a framework to more accurately interpret in vitro drug assay outcomes and guide autophagy modulation research.

• Tolazoline in Islet and Airway Studies: Mechanistic Precisio

  2026-04-24

  Discover the dual mechanisms of Tolazoline as a potent α2-adrenergic receptor antagonist and ATP-sensitive potassium channel blocker. This article delivers a unique, protocol-driven guide for insulin secretion modulation and airway smooth muscle research.

15190 records 1/1013 page Next 12345 下5页 Last page